Carboplatin, French

Obese correction not included

Loading...

Obese correction not included

mg/mL*min
yo

References

  1. Hedy L Kindler. Treatment of Pleural Mesothelioma: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025
  2. Sudeep Gupta. Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025
  3. Stéphanie Gaillard. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025
  4. NA. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney international, 2024
  5. A González-Martín. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology, 2023
  6. L E Hendriks. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology, 2023
  7. A H Calvert. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023
  8. Humera Khurshid. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023
  9. C. Falandry. Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A Randomized Clinical Trial.. JAMA oncology, 2021
  10. D. Miller. Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020
  11. Sheela Rao. International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020
  12. Antonio Rossi. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012
  13. A. Ardizzoni. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.. Journal of the National Cancer Institute, 2007
  14. D. Jodrell. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992
  15. A H Calvert. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989